Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03189446 · OUTCOME

Contributing Cause of Death

Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer · Source last updated 2024-03-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
up to 2 years

What was measured

The contributing cause of death for patients with high risk endometrial cancer

Analysis population: Number of patients who died following protocol treatment

Groups in this outcome

Vaginal Cuff Brachytherapy + Chemotherapy

Vaginal cuff brachytherapy followed by Carboplatin (AUC 6) on day 1and Paclitaxel 80 mg/m2 IV over 1 hour days 1, 8, and 15 X 3 total cycles Vaginal Cuff Brachytherapy: Within 12 weeks of surgery. Either LDR or HDR brachytherapy will be permitted Carboplatin: Carboplatin IV on day 1 of a 21 day cycle for 3 cycles Paclitaxel: Paclitaxel IV on days 1,8 and 15 of a 21 day cycle for 3 cycles

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Vaginal Cuff Brachytherapy + Chemotherapy32

Reported measurements

Source class 1

Unknown cause of death

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Vaginal Cuff Brachytherapy + Chemotherapy1Not reportedNot reportedNot reportedNot reported

Alive

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Vaginal Cuff Brachytherapy + Chemotherapy31Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        1
      title
      Unknown cause of death
    2. measurements
      1. group Id
        OG000
        value
        31
      title
      Alive
denoms
  1. counts
    1. group Id
      OG000
      value
      32
    units
    Participants
description
The contributing cause of death for patients with high risk endometrial cancer
groups
  1. description
    Vaginal cuff brachytherapy followed by Carboplatin (AUC 6) on day 1and Paclitaxel 80 mg/m2 IV over 1 hour days 1, 8, and 15 X 3 total cycles Vaginal Cuff Brachytherapy: Within 12 weeks of surgery. Either LDR or HDR brachytherapy will be permitted Carboplatin: Carboplatin IV on day 1 of a 21 day cycle for 3 cycles Paclitaxel: Paclitaxel IV on days 1,8 and 15 of a 21 day cycle for 3 cycles
    id
    OG000
    title
    Vaginal Cuff Brachytherapy + Chemotherapy
param Type
COUNT_OF_PARTICIPANTS
population Description
Number of patients who died following protocol treatment
reporting Status
POSTED
time Frame
up to 2 years
title
Contributing Cause of Death
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice